These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16732128)

  • 21. Genetic testing for malignant hyperthermia in North America.
    Nelson TE; Rosenberg H; Muldoon SM
    Anesthesiology; 2004 Feb; 100(2):212-4. PubMed ID: 14739790
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant hyperthermia.
    Bouchama A; Hussain S
    Lancet; 1998 Nov; 352(9142):1785. PubMed ID: 9848381
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant.
    Voermans NC; Yang C; Schouten M; Girard T; Stowell K; Riazi S; Kamsteeg EJ; Snoeck M
    Neuromuscul Disord; 2024 Feb; 35():40-41. PubMed ID: 38007345
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant.
    Herdewyn S; De Bleecker J; Janssens L; Symoens S; Milazzo M; De Puydt J
    Neuromuscul Disord; 2024 Feb; 35():39. PubMed ID: 38237271
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical utility gene card for: malignant hyperthermia.
    Rosenberg H; Rueffert H
    Eur J Hum Genet; 2011 Jun; 19(6):. PubMed ID: 21248738
    [No Abstract]   [Full Text] [Related]  

  • 27. Statin-induced adverse effects and malignant hyperthermia susceptibility: comment on the article by Guis et al.
    Vladutiu G
    Arthritis Rheum; 2007 Feb; 57(1):186-7; author reply 187-8. PubMed ID: 17266123
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
    Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
    Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonanesthetic malignant hyperthermia.
    Lehmann-Horn F; Klingler W; Jurkat-Rott K
    Anesthesiology; 2011 Nov; 115(5):915-7. PubMed ID: 21878807
    [No Abstract]   [Full Text] [Related]  

  • 30. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms.
    Duarte ST; Oliveira J; Santos R; Pereira P; Barroso C; Conceição I; Evangelista T
    Muscle Nerve; 2011 Jul; 44(1):102-8. PubMed ID: 21674524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
    Freiermuth D; Poblete B; Singer M; Konrad CJ; Girard T
    Eur J Anaesthesiol; 2013 Oct; 30(10):635-8. PubMed ID: 23736090
    [No Abstract]   [Full Text] [Related]  

  • 34. Confirmation of nonanesthetic-induced malignant hyperthermia.
    Larach MG; Allen GC; Rosenberg H
    Anesthesiology; 2012 Jun; 116(6):1398-9; author reply 1399-400. PubMed ID: 22617205
    [No Abstract]   [Full Text] [Related]  

  • 35. A genetic mystery in malignant hyperthermia 'solved'?
    Schiemann AH; Bjorksten AR; Gillies RL; Hockey BM; Ball C; Pollock N; Bulger T; Stowell KM
    Br J Anaesth; 2018 Sep; 121(3):681-682. PubMed ID: 30115273
    [No Abstract]   [Full Text] [Related]  

  • 36. Out of a cell into this darkened space.
    Parness J; Hogan KJ
    Anesth Analg; 2010 Jul; 111(1):13-6. PubMed ID: 20576962
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant hyperthermia and apparent heat stroke.
    Tobin JR; Jason DR; Challa VR; Nelson TE; Sambuughin N
    JAMA; 2001 Jul; 286(2):168-9. PubMed ID: 11448278
    [No Abstract]   [Full Text] [Related]  

  • 38. Spontaneous occurrence of the disposition to malignant hyperthermia.
    Rueffert H; Olthoff D; Deutrich C
    Anesthesiology; 2004 Mar; 100(3):731-3. PubMed ID: 15108991
    [No Abstract]   [Full Text] [Related]  

  • 39. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 40. Homozygous and heterozygous Arg614Cys mutations (1840C-->T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family.
    Rueffert H; Olthoff D; Deutrich C; Thamm B; Froster UG
    Br J Anaesth; 2001 Aug; 87(2):240-5. PubMed ID: 11493496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.